NanoViricides Files Proxy Statement for Dec. 7 Meeting

TL;DR

NVCR proxy filed for Dec 7 meeting - vote on directors & auditors.

AI Summary

NanoViricides, Inc. filed its definitive proxy statement on October 15, 2024, for its annual meeting of stockholders scheduled for December 7, 2024. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership and proposals, enabling them to make informed voting decisions that can impact the company's future direction and performance.

Risk Assessment

Risk Level: medium — Proxy statements are routine filings, but the specific proposals and the company's financial health can introduce medium-level risk for investors.

Key Numbers

• 12/07/2024 — Annual Meeting Date (Date for shareholder voting)
• 10/15/2024 — Filing Date (Date the proxy statement was submitted)

Key Players & Entities

• NANOVIRICIDES, INC. (company) — Registrant
• Peter Campitiello, Esq. (person) — Legal Counsel
• Lucosky Brookman LLP (company) — Legal Firm
• 06484 (dollar_amount) — ZIP Code

FAQ

Key Financial Figures

• $0.00001 — the holders of common stock, par value $0.00001 per share, of NanoViricides, Inc., a De

Filing Documents

• tm2426151d1_def14a.htm (DEF 14A) — 274KB
• tm2426151d1_def14aimg001.jpg (GRAPHIC) — 3KB
• tm2426151d1_def14aimg002.jpg (GRAPHIC) — 244KB
• tm2426151d1_def14aimg003.jpg (GRAPHIC) — 106KB
• 0001104659-24-108620.txt ( ) — 754KB

From the Filing

DEF 14A 1 tm2426151d1_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 NANOVIRICIDES, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 Copies to: Peter Campitiello, Esq. Lucosky Brookman LLP 101 Wood Avenue South Woodbridge, NJ 08830 Tel: 732-395-4517 Fax: 732-395-4401 NANOVIRICIDES, INC. 1 Controls Drive Shelton, Connecticut 06484 October 15, 2024 To Our Stockholders: On behalf of the Board of Directors of NanoViricides, Inc. (the “Company”), I cordially invite you to attend the Annual Meeting of Stockholders to be held on Saturday, December 7, 2024 at 10:00 a.m., Eastern Daylight Time, at the Hampton Inn & Suites Stamford, 26 Mill River Street, Stamford, CT 06902. At this year’s annual meeting you will be asked to: (i) elect each of one Class I director and two Class II directors who each will serve for a two year term; (ii) approve an award of 10,204 shares of Series A Convertible Preferred Stock to Anil Diwan in connection with the extension of his employment as the Company’s President; (iii) ratify the appointment of our independent registered public accountants; and (iv) transact such other business as may properly come before the annual meeting. The accompanying Notice of Meeting and Proxy Statement describe these matters. We urge you to read this information carefully. Our Board of Directors unanimously recommends that you vote “ FOR ” each proposal. A copy of the 2024 Annual Report is included in this mailing. REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE ANNUAL MEETING, I URGE YOU TO VOTE BY COMPLETING AND RETURNING YOUR PROXY CARD AS SOON AS POSSIBLE. YOUR VOTE IS IMPORTANT AND WILL BE GREATLY APPRECIATED. RETURNING YOUR PROXY CARD WILL ENSURE THAT YOUR VOTE IS COUNTED IF YOU LATER DECIDE NOT TO ATTEND THE ANNUAL MEETING. Cordially, NANOVIRICIDES, INC. Anil Diwan, President and Chairman of the Board of Directors NANOVIRICIDES, INC. 1 Controls Drive Shelton, Connecticut 06484 Notice of Annual Meeting of Stockholders To Be Held on Saturday, December 7, 2024 To Our Stockholders: NOTICE IS HEREBY GIVEN, that the Annual Meeting of Stockholders (the “Annual Meeting”), of NanoViricides, Inc. (the “Company” or “NanoViricides”) will be held on Saturday, December 7, 2024, at 10:00 a.m., Eastern Daylight Time, at [the Hampton Inn & Suites Stamford, 26 Mill River Street, Stamford, CT 06902,] for the following purposes: 1.To re-elect Todd E. Rokita as a Class I director and Makarand Jawadekar and Brian Zucker as Class II directors; each for a two-year term expiring at the 2026 annual meeting of stockholders and until their successor is duly elected and qualified or until their earlier resignation or removal (Proposal 1); 2.To approve an award of 10,204 shares of Series A Convertible Preferred Stock to Anil Diwan in connection with the extension of his employment as the Company’s President (Proposal 2); 3.To ratify the appointment of EisnerAmper, LLP, the Company’s independent registered accounting firm for the fiscal year ending June 30, 2025 (Proposal 3); and 4.To transact such other business as may properly come before the Annual Meeting, including to consider any procedural matters incident to the conduct of the Annual Meeting, such as the postponement of the Annual Meeting in order to solicit additional proxies to vote in favor of the matters presented at the Annual Meeting (Proposal 4). All shareholders are cordially invited to attend the Annual Meeting. Please note that you will be asked to present the admission ticket attached to the accompanying proxy card, plus proof that you are a shareholder of the Company, as well as a valid picture identification, such as a driver’s license or passport, in order to attend the Annual Meeting. The use of cameras, recording devices of any kind and other electronic devices will be prohibited at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, and regardless of the number of shares of common stock you own, you are requested to sign, date and return the enclosed proxy card promptly. Any shareholder of record who submits a proxy card retains the right to revoke suc

View Full Filing

View this DEF 14A filing on SEC EDGAR